QID 375697

Date Published: 2021-08-24

QID 375697: TIBCO FTL Multiple Vulnerabilities (TIBCO FTL - 2021-28819 and TIBCO FTL - 2021-28820)

TIBCO Software Inc.'s TIBCO FTL - Community Edition, TIBCO FTL contains a vulnerability that theoretically allows a low privileged attacker with local access on some versions of the Windows operating system to insert malicious software.

Affected Version:
TIBCO FTL - Community Edition versions 6.5.0 and below

QID Detection Logic(Authenticated)
This QID checks for the vulnerable version of TIBCO FTL on system

Successful exploitation of these vulnerabilities can allow attackers to execute the malicious software inserted by the attacker with the elevated privileges of the component.

CVSS V3 rated as High - 7.8 severity.

CVSS V2 rated as High - 7.2 severity.

Solution

The vendor has released updates to fix the vulnerabilities. Please refer to TIBCO FTL - 2021-28819and TIBCO FTL - 2021-28820 for details.

Vendor References

TIBCO FTL - 2021-28819 - www.tibco.com/support/advisories/2021/03/tibco-security-advisory-march-23-2021-tibco-ftl-2021-28819
TIBCO FTL - 2021-28820 - www.tibco.com/support/advisories/2021/03/tibco-security-advisory-march-23-2021-tibco-ftl-2021-28820

CVEs related to QID 375697

CVE-2021-28819 | CVE-2021-28820 |

Software Advisories

Advisory ID	Software	Component	Link
TIBCO FTL - 2021-28819			www.tibco.com/support/advisories/2021/03/tibco-security-advisory-march-23-2021-tibco-ftl-2021-28819
TIBCO FTL - 2021-28820			www.tibco.com/support/advisories/2021/03/tibco-security-advisory-march-23-2021-tibco-ftl-2021-28820

By selecting these links, you may be leaving CVEreport webspace. We have provided these links to other websites because they may have information that would be of interest to you. No inferences should be drawn on account of other sites being referenced, or not, from this page. There may be other websites that are more appropriate for your purpose. CVEreport does not necessarily endorse the views expressed, or concur with the facts presented on these sites. Further, CVEreport does not endorse any commercial products that may be mentioned on these sites. Please address comments about any linked pages to [email protected].